Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Franco Vito Piantedosi"'
Autor:
Ferdinando Riccardi, Luciana Irtelli, Antonio Rossi, Giovanni De Chiara, Roberto Bianco, Cesare Gridelli, Giuseppe Grimaldi, Giuseppe Airoma, Raffaele Costanzo, Bruno Daniele, Franco Vito Piantedosi, Paolo Maione, Alessandro Morabito
Publikováno v:
Cancer Treatment Reviews. 39:466-472
The current classification of pulmonary neuroendocrine tumours includes four subtypes: low-grade typical carcinoid tumour (TC), intermediate-grade atypical carcinoid tumour (AC), and two high-grade malignancies: large cell neuroendocrine carcinoma an
Autor:
Stefania Russo, Alfonso Illiano, Alfonso De Stefano, Nicla de Rosa, Giancarlo Troncone, Francesco Pepe, Fabiana Vitiello, Franco Vito Piantedosi, Claudio Bellevicine, Pietro Micheli, Maria Salatiello, Danilo Rocco, Caterina De Luca, Chiara Carlomagno, Antonino Iaccarino, Umberto Malapelle
Publikováno v:
Cancer Cytopathology. 121:552-560
BACKGROUND Epidermal growth factor receptor (EGFR) mutations are reliably detected by referral laboratories, even if most lung cancer cytology specimens sent to such laboratories contain very few cells. However, EGFR mutations may be distributed hete
Autor:
Oscar Nappi, Danilo Rocco, Nicla de Rosa, Claudio Bellevicine, Franco Vito Piantedosi, Giancarlo Troncone, Umberto Malapelle, Carlo Crispino, Alfonso Illiano
Publikováno v:
Journal of Clinical Pathology. 65:87-91
In advanced non-small-cell lung carcinomas epidermal growth factor receptor (EGFR) and KRAS testing is often performed on cytology. Liquid-based cytology (LBC), which eliminates the need for slide preparation by clinicians, may be very useful. In 42
Autor:
Umberto, Malapelle, Claudio, Bellevicine, Caterina, De Luca, Maria, Salatiello, Alfonso, De Stefano, Danilo, Rocco, Nicla, de Rosa, Fabiana, Vitiello, Stefania, Russo, Francesco, Pepe, Antonino, Iaccarino, Pietro, Micheli, Alfonso, Illiano, Chiara, Carlomagno, Franco Vito, Piantedosi, Giancarlo, Troncone
Publikováno v:
Cancer cytopathology. 121(10)
Epidermal growth factor receptor (EGFR) mutations are reliably detected by referral laboratories, even if most lung cancer cytology specimens sent to such laboratories contain very few cells. However, EGFR mutations may be distributed heterogeneously
Autor:
Alfonso Illiano, Giancarlo Troncone, Umberto Malapelle, Fabiana Vitiello, Claudio Bellevicine, Franco Vito Piantedosi, Danilo Rocco, Nicla de Rosa, Oscar Nappi
Publikováno v:
Journal of clinical pathology. 65(6)
Currently, there is a trend towards an increasing use of liquid-based cytology (LBC) to diagnose non-small cell lung cancer. In this study, to detect epidermal growth factor receptor mutations, different molecular techniques were applied to LBC sampl
Autor:
Ornella Belvedere, Alba A. Brandes, Paola Venturino, Domenico Amoroso, Marcello Tiseo, Salvatore Siena, Roberto Labianca, Stefano Cascinu, Andrea Ardizzoni, Cesare Gridelli, Francesco Grossi, Lucio Crinò, Brunello Valentino, Franco Vito Piantedosi, Alessandra Bearz
Publikováno v:
Lung cancer (Amsterdam, Netherlands). 64(2)
Background: Erlotinib demonstrated significantly prolonged survival versus placebo in patients with advanced NSCLC who had progressed after standard chemotherapy. TRUST is a phase IV trial initiated to provide erlotinib access to patients with advanc
Autor:
V. Filipazzi, Alessandro Morabito, Cesare Gridelli, Sergio Federico Robbiati, Francesco Perrone, Vito Lorusso, Paolo Maione, Franco Vito Piantedosi, Luigi Manzione, Adolfo Favaretto, Alfonso Illiano, Francesco Carrozza, Alessandra Bearz, Ciro Gallo, Rosario Vincenzo Iaffaioli
Publikováno v:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 25(29)
Purpose Two phase I/II trials were done to evaluate the feasibility of cisplatin combined with gemcitabine or vinorelbine in elderly patients with advanced non–small-cell lung cancer (NSCLC). Patients and Methods Patients with advanced NSCLC who we
Autor:
Lesley Seymour, S. Cigolari, Santi Barbera, Frances A. Shepherd, Ciro Gallo, Francesco Perrone, Franco Vito Piantedosi, Giovanni Pietro Ianniello, Paolo Chiodini, Luigi Manzione, Massimo Di Maio, Alfonso Illiano, Federico Castiglione, Sergio Federico Robbiati, E. Piazza, Enzo Veltri, Francesco Rosetti, Luciano Frontini, Cesare Gridelli, Vittorio Gebbia
Summary Background Chemotherapy is the standard treatment for advanced non-small-cell lung cancer, and myelosuppression is a common side-effect. We aimed to assess whether haematological toxic effects could be a biological measure of drug activity an
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3ff9a39779231189dc92cea5de709894
http://hdl.handle.net/10447/11476
http://hdl.handle.net/10447/11476
Autor:
Umberto Malapelle, Nicla de Rosa, Claudio Bellevicine, Danilo Rocco, Fabiana Vitiello, Franco Vito Piantedosi, Alfonso Illiano, Oscar Nappi, Giancarlo Troncone
Publikováno v:
Journal of Clinical Pathology; Jun2012, Vol. 65 Issue 6, p561-564, 4p, 1 Diagram, 1 Chart, 2 Graphs